Clinical Trial Update: Efficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intravenous palonosetron for prevention of chemotherapy-induced nausea and vomiting in pediatric patients has completed, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Palonosetron (palonosetron)

Snippet

Sponsor: Helsinn Healthcare SA | Conditions: Chemotherapy-Induced Nausea and Vomiting | Phase 3 | Status: COMPLETED | Results posted: 2014-07-28